GlassScriptPhysician profile
Savas Mavridis
NPI 1013912070
$7,047.47
in general payments reported to CMS, 2019-2025
35 companies · $777 in 2025
The $777 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $1,331 · 2021: $633 · 2022: $587 · 2023: $2,055 · 2024: $508 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,875 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,874.69 |
| Travel and Lodging | $466.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,580.57 | 2021-2023 | Angiovac |
| Atricure, INC. | $1,515.84 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Boston Scientific Corporation | $602.83 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $550.95 | 2019-2025 | Lifevest |
| Getinge USA Sales, LLC | $412.17 | 2019-2025 | Vasoview Hemopro 2, Cardiohelp, Heartstring III Proximal Seal |
| Abbott Laboratories | $409.17 | 2019-2025 | Aveir, Jot Dx, Navitor |
| Medtronic, INC. | $379.80 | 2022-2025 | Corevalve Evolut R, Endurant Iis, Cobalt Dr Mri Surescan |
| Astrazeneca Pharmaceuticals LP | $224.79 | 2020-2023 | Farxiga, Tagrisso |
| Medical Device Business Services, INC. | $128.75 | 2023 | Vistaseal |
| Zimmer Biomet Holdings, INC. | $126.39 | 2021-2023 | Sternalock Blu System |
| Ethicon INC. | $99.32 | 2022 | |
| Cerus Corporation | $87.00 | 2025 | Intercept Blood System For Platelets |
| Stryker Corporation | $80.38 | 2025 | Venacore Thrombectomy Catheter, Artix Mt, Flowtriever Catheter, S |
| Irhythm Technologies, INC. | $73.86 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Merck Sharp & Dohme LLC | $66.90 | 2023-2025 | Keytruda |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $65.13 | 2019-2022 | |
| Medtronic Vascular, INC. | $62.72 | 2019-2020 | |
| Smith+Nephew, INC. | $53.61 | 2020-2025 | Collagenase Santyl |
| Livanova USA, INC. | $51.94 | 2019 | |
| Mid-Atlantic Surgical Systems, LLC | $47.07 | 2023-2025 | |
| Becton, Dickinson and Company | $44.95 | 2025 | Arista |
| Novo Nordisk INC | $39.48 | 2019 | |
| Baxter Healthcare | $39.18 | 2025 | Perclot |
| Edwards Lifesciences Corporation | $38.06 | 2019-2022 | |
| Corcym INC | $37.56 | 2021-2022 | |
| Innovation Technologies INC | $33.34 | 2022 | |
| Abiomed | $32.74 | 2024 | Impella |
| Octapharma USA, INC. | $28.80 | 2025 | Fibryga |
| Kls-Martin L.P. | $22.14 | 2022 | |
| Artivion, INC. | $20.88 | 2025 | Amds-Ascyrus Medical |
| Depuy Synthes Sales INC. | $20.60 | 2022 | |
| Ethicon US, LLC | $18.27 | 2022 | |
| Inari Medical, INC. | $17.64 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Integra Lifesciences Corporation | $17.42 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $17.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savas Mavridis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.